White Lyophilized Powder Recombinant IGF 1 Long R3 Low Endotoxin For Research

 
White Lyophilized Powder Recombinant IGF 1 Long R3 Low Endotoxin For Research ​
 
Description
 
Insulin-like growth factor-1 (IGF-1) is a hormone similar in molecular structure to insulin. It primarily functions through binding to its specific receptor, the insulin-like growth factor 1 receptor (IGF1R). IGF-1 is one of the most potent natural activators of the AKT signaling pathway, which stimulates cell growth and proliferation, and inhibits cell apoptosis. LR3 IGF-1 (Long Arg3 IGF-1) is an 83 amino acid analog of IGF-1 comprising the complete human IGF-1 sequence with the substitution of an Arg for the Glu at position 3 (hence R3), and a 13 amino acid extension peptide at the N-terminus. The LR3 IGF-1 has much higher stability and biological activity. IGF-1 LR3 is widely regarded as a powerful alternative to insulin and can be used for cell culture and other experimental studies.
 
Finished rhIGF-1 LR3 is white lyophilized powder and its endotoxin content is less than 5.0 EU / mg.
 
 
Quick Details
 

1. Other Names: rhIGF-1 LR3, Recombinant IGF 1 Long R3, Long R3 IGF-1, LR3 IGF-1
2. Brand Name: Oryzogen
3. Purity: Greater than 90% as determined by SDS-PAGE
4. Source: Yeast
5. Formulation: rhIGF-1 LR3 is lyophilized with saline.
6. Biological activity: The ED50 is ≤1ng/ml determined by a cell proliferation assay using
7. Storage and Handling: -20℃ for 2 years
8. Restrictions: FOR RESEARCH, LABORATORY AND MANUFACTURE USE,BODYBUILDING.

 

 
Advantages
 
1. Wuhan Healthgen Biotechnology Corp. is a private company founded in 2006. We specialize in molecular pharmaceutical technology research and high-tech innovation-oriented product development, which is developing, manufacturing and marketing a series of recombinant proteins and growth factors by rice endosperm platform. We have 400 square meters of research center, in which 30% of the research personnels have doctoral degree and major in different directions of the research and development.
 
Healthgen Biotech has strong capability in developing a series of biological products.
 
2. Healthgen Biotech quality control systerm has been certified by ISO 9001:2015 and ensure standardized process as well as qualified products.
 
3. Healthgen Biotech rhIGF-1 LR3 has excellent batch consistency. Using self-pollination rice as the bioreactor to express the rhIGF-1 LR3 with the world's advanced facility and top production proceeding to extract and purify the rhIGF-1 LR3, Healthgen Biotech can ensure the excellent consistency of rhIGF-1 LR3 from different batches.
 
 
Supplemental Description
 
Achievement and Honor
 
Healthgen Biotech obtained a number of patented technologies with independent intellectual property rights, including applied 9 national patents and 6 authorized patents, applied 7 international patents and 3 authorized patents. The international patents cover to United States, Japan, Europe and Canada. Moreover, two patents were authorized both by the Republic of South Africa and the United States. Based on rice endosperm specific expression technical platform-Oryz^HiExp, Healthgen Biotech, aim at the international forefront, takes the market as the orientation and enhances biotechnology innovation and engineering research, has won numerous awards.
 
Scientific Research Projects:
 
Major projects for New Drug Discovery, 3 projects of "Major projects of new varieties of genetically modified organisms” of the Ministry of Agriculture, National Ministry of Science and high Technology “863 plan”, National Ministry of Science and Technology Innovation fund, Pilot development of strategic emerging industries project
 
Talents Scheme:
 
“Thousand Talents program” of the National Central Organization Department, "Hundred Talents Program" of the Organization Department of Hubei Province, "3551 talents program” of the East Lake high-technology development zone , Top 10 "Venture Eagle" entrepreneurs.
 
Research Centers and Awards:
 
Wuhan National Biological Industry Base protein purification center, Hubei Molecular Biopharmaceutical Engineering Research Center, 2013 National Science and Technology Invention Award, 2012 Hubei Provincial Science and Technology Invention Award, 2013 China Patent Excellence Award, High-tech enterprise, Agricultural science and technology enterprise, Patent advantage enterprise.